Morphometric analysis of ductal carcinoma in situ identifies features associated with low risk of progression to invasive breast cancer. (November 2022) - Leite, M.; Melillo, X.; Lam, N.; Vonk, S.; de Bruijn, B.; Sanders, J.; Almekinders, M.; Visser, L.; Groen, E.; Van der Borden, C.; Mulder, L.; Kristel, P.; et al.